CIMT is a well-known marker of subclinical atherosclerosis and its measurement is a noninvasive and inexpensive method of detecting subclinical atherosclerosis; it is in relationship to adiponectin, leptin and hsCRP. This evidence concerns the gene LEP and atherosclerosis.